T829-2104 Screening compound: N-{2-[benzyl(ethyl)amino]ethyl}-2,5-dimethyl-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide

T829-2104 Screening compound: N-{2-[benzyl(ethyl)amino]ethyl}-2,5-dimethyl-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide
T829-2104 Screening compound: N-{2-[benzyl(ethyl)amino]ethyl}-2,5-dimethyl-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound T829-2104
N-{2-[benzyl(ethyl)amino]ethyl}-2,5-dimethyl-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T829-2104

Molecular Formula

C21H29N3O2 (C21 H29 N3 O2)

Compound Name

N-{2-[benzyl(ethyl)amino]ethyl}-2,5-dimethyl-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide

IUPAC name

N-{2-[benzyl(ethyl)amino]ethyl}-25-dimethyl-4H5H6H7H-furo[32-c]pyridine-3-carboxamide

SMILES

CCN(CCNC(c1c(C)oc2c1CN(C)CC2)=O)Cc1ccccc1

InChI

InChI=1S/C21H29N3O2/c1-4-24(14-17-8-6-5-7-9-17)13-11-22-21(25)20-16(2)26-19-10-12-23(3)15-18(19)20/h5-9H,4,10-15H2,1-3H3,(H,22,25)

InChI Key

ILVSAMHHDNLHKB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD28993489

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

355.48

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

1.952

Distribution Coefficient, logD

-3.054

Water Solubility, LogSw

-2.37

Polar Surface Area

39.738

Acid Dissociation Constant (pKa)

12.57

Base Dissociation Constant (pKb)

11.43

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

47.62

T829-2104 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Antiviral Library (67538 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Cancer
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with T829-2104 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T829-2104?
Check Price and Availability of T829-2104, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T829-2104 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T829-2104
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T829-2104
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T829-2104 available by request